Latest News and Press Releases

 Oslo, Norway, 25th of October 2023 Vistin Pharma ASA (Vistin Pharma, OSE: VISTIN) today announces the financial results for the third quarter of 2023. Vistin delivers another strong quarter with...

Oslo, Norway, 25th of October 2023 The Board of Directors of Vistin Pharma ASA has appointed Magnus Tolleshaug as the new CEO of Vistin Pharma from 1st of January 2024. Magnus Tolleshaug is...

Oslo, Norway, 18 October 2023 Vistin Pharma ASA will release its third quarter results on Wednesday 25th of October 2023. Vistin Pharma will host a conference call for all shareholders and interested...

Saga Pure ASA has on 18 September 2023 purchased 100,000 shares in Vistin Pharma ASA at NOK 23,50 per share. After the transaction Saga Pure ASA has a holding of 100,000 shares, corresponding to 0.23...

Ferncliff Listed DAI AS has on 25 August 2023 purchased 200,000 shares in Vistin Pharma ASA at NOK 21 per share. After the transaction Ferncliff Listed DAI AS has a holding of 1,234,280 shares,...

Oslo, Norway, 23rd of August 2023 Vistin Pharma ASA (Vistin Pharma, OSE: VISTIN) today announces the financial results for the second quarter and first half of 2023. Revenue in the second quarter...

Oslo, Norway, 16 August 2023 Vistin Pharma ASA will release its second quarter and YTD 2023 results on Wednesday 23rd of August 2023. Vistin Pharma will host a conference call for all shareholders...

4 July 2023: Vistin Pharma ASA (the “Company”) has on 4 July 2023 sold shares to members of its management team for its long-term incentive plan (LTIP), as approved by the general meeting on the 22...

4 July 2023: Reference is made to the stock exchange release of Vistin Pharma ASA (“Vistin” or the "Company") dated 30 June 2023 at 07:30 hours CEST concerning an offer to buy back shares (the...

30 June 2023: Vistin Pharma ASA (the “Company”) has decided to launch an offer to all shareholders in the Company to buy back up to 250,000 shares in the Company in connection with its Long Term...